Category: Cancer Treatment
United States Cancer Treatment
-
2025 United States Cancer Biomarkers Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Medical Device Mfg. industry. The global market is expected to increase from USD xx billion in 2026 to USD xx billion by 2031, at a CAGR of xx% from 2026 to 2031. Estimates on equipment ... Read More
-
2024-2029 US Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 100 Tests - Abused Drugs, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Assays - High-Growth Opportunities for Suppliers, Competitive Analysis and Growth Strategies, Latest Technologies and Instrumentation Pipeline
... Opportunities for Suppliers, Competitive Analysis and Growth Strategies, Latest Technologies and Instrumentation Pipeline LeadingMarketResearch’s new report is a study of the major business opportunities emerging in the U.S. immunodiagnostic market during the next five years. ... Read More
-
2024-2029 Global Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 100 Tests in the US, Europe and Japan - Abused Drugs, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Assays - High-Growth Opportunities for Suppliers, Competitive Analysis and Growth Strategies, Latest Technologies and Instrumentation Pipeline
... TDM and Other Assays - High-Growth Opportunities for Suppliers, Competitive Analysis and Growth Strategies, Latest Technologies and Instrumentation Pipeline LeadingMarketResearch.com's new report is a seven-country strategic analysis of major business opportunities emerging in the immunodiagnostic ... Read More
-
2024-2029 Global Cancer Diagnostics Market Segmentation Analysis: US, Europe, Japan - Cancer Clinics, Commercial Labs, Hospitals, Physician Offices - Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Competitive Analysis, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Growth Opportunities This new report from LeadingMarketResearch.com is based on a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the ... Read More
-
2024-2029 Nucleic Acid Testing (NAT) Market: US, Europe, Japan - Supplier Sales and Shares by Test, Volume and Sales Forecasts for 100 Infectious, Cancer and Genetic Diseases, Forensic and Paternity Testing/HLA Typing - Technological Breakthroughs, Emerging Tests, Competitive Analysis
... Emerging Tests, Competitive Analysis This new seven-country study from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next ... Read More
-
2024 United States Breast Cancer Therapeutics Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 United States Cancer Diagnostics Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 United States Immunotherapy Drugs Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 United States Lung Cancer Surgery Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
2024 United States Pd-1 And Pd-L1 Inhibitors Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... within the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product ... Read More
-
2024 United States Cancer Monocolonal Antibodies Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 United States Cancer Immunotherapy Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 United States Cancer Supportive Care Drugs Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
Antibody Drug Conjugate Market by Target Disease Indication (Breast Cancer, B-cell Lymphoma, Lung Cancer, Multiple Myeloma, Acute Lymphoblastic Leukemia, Gastric Cancer, Renal Cancer, Cervical Cancer and Other Target Disease Indications), Therapeutic Area (Hematological Cancer and Solid Tumor), Linker (Valine-Citrulline, Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate, Tetrapeptide-based Linker, Maleimide, Maleimidocaproyl, Valine-Alanine, Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (AcBut) and Other Linkers), Payload (Monomethyl Auristatin E, DM1, Duocarmycin, SN-38 / Irinotecan, Monomethyl Auristatin F, SG3199, Ozogamicin, DM4 and Other Payloads), Target Antigens (HER-2 (ERBB2), CD79b, Trop-2, BCMA (TNFRSF17 / BCM), CD19, CD22, Tissue Factor, CD30, CEACAM5, Nectin 4 and Others) And Key Geographical Regions (North America (US, Canada), Europe (Germany, UK, France, Italy, Spain), and Asia-Pacific (China, Australia, Japan)): Industry Trends and Global Forecasts, Till 2035
... Solid Tumor), Linker (Valine-Citrulline, Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate, Tetrapeptide-based Linker, Maleimide, Maleimidocaproyl, Valine-Alanine, Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (AcBut) and Other Linkers), Payload (Monomethyl Auristatin E, DM1, Duocarmycin, SN-38 / Irinotecan, Monomethyl Auristatin F, SG3199, Ozogamicin, DM4 and ... Read More
-
U.S. Sterile Injectables Market, By Molecule Type (Large Molecule and Small Molecule), By Drug Type (Monoclonal Antibody (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, and Others), By Therapeutic Application (Cancer, Metabolic Disorder, Cardiovascular Diseases, Infectious Diseases, Musculoskeletal Disorders, and Others), By Route of Administration (Subcutaneous, Intravenous, Intramuscular, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
... Musculoskeletal Disorders, and Others), By Route of Administration (Subcutaneous, Intravenous, Intramuscular, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) Sterile injectables refer to parenteral drugs that are administered via various injection ... Read More
-
Prostate Cancer Diagnostics
... by 2030, growing at a CAGR of 13.1% over the analysis period 2023-2030. Preliminary Test, one of the segments analyzed in the report, is expected to record a 12.4% CAGR and reach US$10.0 Billion by ... Read More
-
United States Proton Therapy Market Report Forecast by Indication (Head & Neck Cancer, Sarcoma, Pediatric Cancer, Gastro-intestinal Cancer, Prostate Cancer, Lung Cancer, Set-up Type (Single Room, Multi – Room). States and Company Analysis 2025-2033
... States Proton Therapy Market Size United States Proton Therapy market had reached US$1,046.62 million in 2024 and is estimated to reach US$2,670.80 million during the forecast period from 2025 to 2033 at a compound annual ... Read More
-
2024 United States Cancer Biomarkers Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are ... Read More
-
2024 United States Cancer Registry Software Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 United States Cancer-Tumor Profiling Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are ... Read More
-
United States In-Vitro Diagnostics (IVD) Market, By Product and Services (Reagents & Kits, Instruments, Software & Services); By Technique (Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, Immunodiagnostics, Hematology, Others); By Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, Others); By End User (Standalone Laboratories, Hospitals, Academic & Medical Schools, Point of Care (PoC), Others), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, Others); By End User (Standalone Laboratories, Hospitals, Academic & Medical Schools, Point of Care (PoC), Others), Trend Analysis, Competitive Landscape & Forecast, 2019–2030 United States In-Vitro Diagnostics (IVD) ... Read More
-
2024 US Hospital Cancer Diagnostics Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for Major Tumor Markers, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
... pages and 50 tables. The report presents a comprehensive analysis of the US hospital cancer diagnostics market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and ... Read More
-
North America Veterinary Oncology Market Size, Share & Trends Analysis Report By Animal Type (Canine, Feline), By Therapy (Radiotherapy, Surgery, Chemotherapy), By Cancer (Skin Cancer, Lymphoma), By Country (U.S., Canada), And Segment Forecasts, 2024 - 20
... 2030 North America Veterinary Oncology Market Growth & Trends The North America veterinary oncology market size is expected to reach USD 1.22 billion by 2030, according to a new report by Grand View Research, Inc. ... Read More
-
Health Fundraising Organizations - 2024 U.S. Market Research Report with Updated Recession Risk Forecasts
... in the United States with over 100+ data sets covering 2015-2028. This Kentley Insights report is full of industry insights including historical and forecasted market size, revenue and industry breakdowns by product lines, size of ... Read More
-
2024 What's Next for US Diagnostics Market? - Supplier Shares and Strategies, 2023-2028 Volume and Sales Forecasts for 500 Tests - Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
... Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM This new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2023 supplier shares, strategies, as well as 2023-2028 volume and sales forecasts for 500 ... Read More
Research Assistance
